The impact of immediate breast reconstruction on the time to delivery of adjuvant therapy: the iBRA-2 study

Rachel L. O’Connell,T. Rattay,R. Dave,A. Trickey,Joanna Skillman,Nicola L. P. Barnes,Matthew D. Gardiner,A. Harnett,S. Potter,C. Holcombe,Nicola L. P. Barnes,J. Blazeby,E. Conroy,R. Dave,Matthew D. Gardiner,A. Harnett,C. Holcombe,C. O’Brien,Rachel L. O’Connell,S. Potter,T. Rattay,Joanna Skillman,P. Williamson,A. Curnier,A. Tadros,I. Depasquale,Y. Masannat,E. Smyth,Mairi Fuller,R. Bourne,S. Heys,I. Hamo,Fatima Aloraifi,L. Fopp,Radhika Bali,S. Bache,S. Benyon,M. Irwin,Amit Agrawal,C. Malata,C. Murphy,A. Misky,D. Chicken,Nassreen Abdullah,Arnold D Hill,C. Cullinane,G. Irwin,S. McIntosh,Sigi Refsum,S. Sloan,P. Mallon,C. Sirianni,I. Khattak,Geerthan Nagachandra,P. Kiruparan,Debasish Debanth,S. Davey,T. Curran,M. Svenning,S. Govindarajulu,Z. Rayter,R. Ainsworth,S. Cawthorn,A. Sahu,Sherif M Wilson,E. Prousskaia,A. Accurso,N. Rocco,R. D. Micco,G. Limite,R. Ceccarino,Raffaele Liccardo,G. Coco,M. Nizamoglu,M. Morgan,V. Ramakrishnan,G. Catanuto,A. Wilkins,P. McManus,P. Kneeshaw,K. Grover,T. Mahapatra,B. Wooler,B. Elahi,N. Ihsan,A. Bucknor,D. Reissis,J. Hunter,Simon N. Wood,N. Jallali,F. Henry,L. Verjee,Jason Lee,Shazia Khan,I. Azmy,J. Massey,Ciaran Hollywood,Michael Oluwajana,S. Bathla,J. Seward,C. Harding-Mackean,R. Lane,K. Murali,B. Biswas,P. Trapszo,S. Seetharam,K. Kennedy,L. Alder,T. Graja,K. Amin,J. Kokan,C. Roshanlall,Emma C. Gill,D. Kulkarni,J. Dixon,O. Young,T. Saleem,M. Biddle,Marie Kearns,E. Weiler-mithoff,B. Chew,A. Malyon,J. Scott,D. McGill,Iain Mackay,S. Bains,S. Barrows,S. Pilgrim,S. Shokuhi,K. Lambert,Frances Kenny,K. Valassiadou,M. Kaushik,J. Krupa,D. Dragoumis,Quratul Ain,P. Lampropoulos,S. Moss,H. Khalil,A. Haq,B. Balasubramanian,P. Charalampoudis,H. Hamed,A. Kothari,Tibor Kovács,M. Douek,I. Mehmood,B. Ray,M. Adelekan,Laura Humphreys,S. Tayeh,C. Choy,L. Parvanta,S. Michieletto,T. Saibene,J. O'Brien,S. Down,S. Downey,J. Pereira,A. Sami,A. Gvaramadze,J. Jibril,D. Thekkinkattil,S. Udayasankar,S. Khawaja,Yousef Shariaha,S. Holt,R. James,H. Rizki,K. Kirkpatrick,D. Ravichandran,D. Shrestha,E. Barua,D. Akolekar,A. Hamad,E. Kleidi,S. Hignett,V. Pope,S. Naseem,J. Isherwood,R. Soulsby,Amanda Taylor,K. Chin,D. Nguyen,Francesca L. Guest,Amanda Thorne,V. Lefemine,Christopher M. Kirchhoff,D. Murphy,Michelle C. I. Lo,Ruth Harcourt,S. Pain,Maged I. Hussien,K. Zechmeister,E. Sassoon,A. Figus,R. Haywood,R. Ali,Su Alexander,K. Geropantas,D. Epurescu,Rebecca Lewis,O. Fafemi,J. Gahir,T. Gandamihardja,Jennett Kelsall,N. Muhibullah,C. Otieno,F. Mazari,Marta Dauria,L. Whisker,D. Macmillan,E. Gutteridge,T. Rasheed,Hazem Khout,K. Ásgeirsson,S. McCulley,M. D. Mariniello,M. Roncella,M. Ghilli,L. Colizzi,E. Rossetti,Lo Russo Marzia,L. Fustaino,Alessandro Quattrini Li,K. Harvey,R. Windle,D. Remoundos,P. Roy,G. Maclean,A. Adwani,E. Popa,S. Goh,G. Shetty,S. Clark,L. Bernaudo,Avi Agrawal,L. Mansfield,Sally Tebbal,Ashraf Patel,V. Grassi,O. Pujji,K. Hamnett,N. Basu,E. Granger,Michael Durbar,Panagiotis Pikoulas,C. Garnsey,Philip Walker,Angela J Vollermere,I. Michalakis,Robin Jones,M. Youssef,C. Ives,Mohammad Masood,J. Dunn,S. Olsen,D. Ferguson,R. Tillett,A. Allan,Alexander Woollard,Rebecca Canny,Alexander Woollard,A. Mosahebi,S. Hamilton,S. Ghali,Dan J Marsh,J. Chana,Nilesh M. Sojitra,I. Younis,D. Rainsbury,N. Chand,Vasileios Kalles,A. Stebbing,K. Harris,S. Laws,A. Tansley,G. Mitchell,E. de Sousa,J. Henderson,M. Chandrashekar,B. Pereira,C. Constantinou,D. Elfadl,F. Irakleidis,I. Hernan,Miriam Byrne,Natalie To,J. Rusby,P. Barry,Katerine Krupa,W. Allum,F. MacNeill,N. Roche,G. Gui,K. Ramsey,P. Harris,Stuart James,K. Power,R. Sutton,J. Mcintosh,N. Laurence,L. Maclennan,R. Milligan,H. Cain,A. Critchley,J. O’Donoghue,Loraine Kalra,N. Collis,G. Weston-Petrides,R. Fiddes,V. Brown,A. Aertssen,Diana Slade-Sharman,Mansoor Khan,C. McGuiness,V. Amorosi,Santanelli di Pompeo Fabio,G. Exarchos,N. Jiwa,Jennifer Hu,S. Ledwidge,L. Johnson,A. Peel,Naseem Dhooma,E. Farrell,L. Devane,R. Tevlin,E. McDermott,R. Prichard,D. Evoy,J. Rothwell,J. Geraghty,Colin Morrison,C. Lawlor,F. Langlands,Lauren Taylor,P. Turton,R. Achuthan,K. Horgan,S. Mckenzie,B. Hogan,M. Lansdown,C. Navin,L. Sherwin,C. Mortimer,Neeraj Garg,Rahma I. Adam,T. Arif,Zbigniew Kryjak,Deedar Ali,R. Sowdi,Elena Fage,S. Mylvaganam,P. Matey,R. Vidya,T. Sircar,O. Asaad,P. Bhaskar,M. Dordea,Ada Chrysafi,D. McCartan,R. Dave,Rachel Foster,Rebecca L. Wilson,Sylvia Okwemba,Y. Majeed,V. Mathen,J. Murphy,Nicola L. P. Barnes,A. Gandhi,J. Harvey,C. Kirwan,Richard P. Johnson,Krupali Patel,M. Ribas,N. Vigneswaran,T. Challoner,Alan Park,M. Rizkalla,A. Tomlins,K. McEvoy,S. Jafferbhoy,S. Soumian,S. Narayanan,R. Kirby,Sladana Bajrusevic,J. Maalo,M. Charalambous,L. Lai,K. Chong,S. Thomson,S. Monib,L. Chagla,R. Audisio,R. Taghizadeh,A. Iqbal,K. James,Maria Callaghan,S. Poonawala,J. Lund,R. Vinayagam,S. Thrush,R. Thomas,M. Mullan,Jevan Taylor,Ryo Yoshimura,T. Mathew,Bennet Jones,K. Munot,R. Nasr,J. Piper,Deena El-Sharief,M. Mustafa

Published 2019 in British Journal of Cancer

ABSTRACT

Immediate breast reconstruction (IBR) is routinely offered to improve quality-of-life for women requiring mastectomy, but there are concerns that more complex surgery may delay adjuvant oncological treatments and compromise long-term outcomes. High-quality evidence is lacking. The iBRA-2 study aimed to investigate the impact of IBR on time to adjuvant therapy. Consecutive women undergoing mastectomy ± IBR for breast cancer July–December, 2016 were included. Patient demographics, operative, oncological and complication data were collected. Time from last definitive cancer surgery to first adjuvant treatment for patients undergoing mastectomy ± IBR were compared and risk factors associated with delays explored. A total of 2540 patients were recruited from 76 centres; 1008 (39.7%) underwent IBR (implant-only [n = 675, 26.6%]; pedicled flaps [n = 105,4.1%] and free-flaps [n = 228, 8.9%]). Complications requiring re-admission or re-operation were significantly more common in patients undergoing IBR than those receiving mastectomy. Adjuvant chemotherapy or radiotherapy was required by 1235 (48.6%) patients. No clinically significant differences were seen in time to adjuvant therapy between patient groups but major complications irrespective of surgery received were significantly associated with treatment delays. IBR does not result in clinically significant delays to adjuvant therapy, but post-operative complications are associated with treatment delays. Strategies to minimise complications, including careful patient selection, are required to improve outcomes for patients.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-34 of 34 references · Page 1 of 1

CITED BY

Showing 1-64 of 64 citing papers · Page 1 of 1